NCT01669629.
Methods | RCT, cross‐over design |
Participants |
Inclusion criteria: between 18 and 45 years of age; willing to wear the study lenses for at least 8 hours per day, 7 days per week; current successful SCL wearer; spherical prescription −1.00 D to −6.00 D; astigmatism less than or equal to 0.75 D; BCVA of 20/30 (6/9) or better Exclusion criteria: ocular or systemic diseases or treatments that may interfere with contact lens wear; clinically significant biomicroscopy findings (Grade 3 or 4); previous hard contact lens use; pregnancy or lactation; no extended wear in the last 3 months |
Interventions | Delefilcon A
Etafilcon A
|
Outcomes |
Primary outcome:
Secondary outcomes:
|
Notes | Sponsorship source: Johnson & Johnson Vision Care Inc. Author's name: Kathy Osborn Institution: Vistakon Comments: whether the analysis accounted for cross‐over design was unclear |